Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Abivax
Abivax
(ABVX)
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
chronic hepatitis b
Antithrombin iii
ulcerative colitis
Obefazimod
healthy volunteers/patients
,
hiv infections
,
rheumatoid arthritis
,
ulcerative colitis
Alfacalcidol
ulcerative colitis
Abx-464
healthy volunteers/patients
,
hiv infections
,
rheumatoid arthritis
,
ulcerative colitis
Abx196
liver neoplasms
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use